• Home
• Responsibility
• CR Report 2004
• Community investment
• Value of community investment

Value of community investment

GSK donations were valued at £328 million ($600 million) in 2004, and supported programmes in more than 100 countries. This is equivalent to 5.4% of pre-tax profits.

This figure includes medicines worth £203.5 million ($372 million) donated to low-income patients in the US through our Patient Assistance Programs, and £50 million ($92 million) of humanitarian product donations for under-served communities around the world.

Product donations are valued at wholesale acquisition cost. This is the wholesale list price, not including discounts, which is the standard pharmaceutical industry method for valuing product donations.

Our total community investment also includes £17.7 million ($32 million) in management costs and £48.4 million ($89 million) in cash grants.

GSK is a member of the UK’s Percent Club for companies which donate at least 1% of their pre-tax profits to charitable causes. GSK is regularly one of the top companies in the UK’s Guardian Giving List which lists FTSE 100 companies by the percentage of pre-tax profits contributed to charitable causes.

Product	260.0
Cash	48.4
Management Costs	17.7
In-kind	1.7

Health	44.3
Education	37.8
Arts and Culture	2.1
Environment	2.0
Other	13.8

We are members of the UK’s London Benchmarking Group (LBG) and the Committee to Encourage Corporate Philanthropy (CECP) in the US. We report our donations in line with the guidelines set by the CECP, which values our medicines at wholesale acquisition cost, in line with other pharmaceutical companies.

Back to top